Myriad, GeneSight and UnitedHealth
The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...
Election season is in full swing, but as anyone can tell you, campaigns begin to enter their full speed much earlier in the ...
Piper Sandler thinks Myriad Genetics (MYGN), which has seen its shares fall nearly 22% on Friday morning, is trading down on a coverage decision on GeneSight by UnitedHealth (UNH), which will take ...
With a simple cheek swab, the GeneSight test generates a report that gives healthcare providers insight into how a patient may metabolize or respond to certain psychiatric medications.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback